RecruitingNot ApplicableNCT06809660

Effects of Endocrine Disruptors on the Gut Microbiota and Assessment of Their Impact on Colorectal Cancer Development (PERMICA)

Effects of Endocrine Disruptors on the Gut Microbiota and Assessment of Their Impact on Colorectal Cancer Development


Sponsor

Poitiers University Hospital

Enrollment

200 participants

Start Date

Jan 21, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Colorectal cancer is the third most common cancer worldwide, yet it was the second leading cause of cancer-related deaths in 2020. The average French population faces a colorectal cancer risk partly linked to lifestyle factors. The majority of colorectal cancer cases (approximately 85%) are not caused by hereditary mutations. Environmental factors, such as lifestyle or diet (notably through endocrine disruptors), can affect the gut microbiota (a collection of microorganisms - bacteria, viruses, parasites, and fungi - residing in the intestinal environment) and lead to disturbances in its composition, referred to as dysbiosis. While the mechanisms underlying dysbiosis associated with colorectal cancer remain poorly understood, the involvement of certain ingested substances, known as xenobiotics, is increasingly suspected, including endocrine disruptors. Among the most common endocrine disruptors found in water and food are parabens and phthalates, which will be examined in detail in this study. These substances may be directly involved in the development of colorectal cancer and in response to its treatment. The main objective of this studie is to characterize the relationship between colorectal cancer diagnosis, activity/composition of the gut microbiota, and patients' exposure to selected endocrine disruptors, particularly parabens and phthalates.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating how everyday chemicals called endocrine disruptors — found in plastics, food packaging, and personal care products — may affect the gut microbiome (the community of bacteria in your digestive system) and potentially contribute to health problems. **You may be eligible if...** - You meet the age requirements for the study - You are willing to provide biological samples (such as blood, urine, or stool) - You are generally healthy or fit the profile being studied **You may NOT be eligible if...** - You have conditions that would significantly alter your gut microbiome (such as recent antibiotic use or inflammatory bowel disease) - You are pregnant or breastfeeding - You are currently enrolled in another study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERCollection of biological samples and clinical data

* Collection of a hair sample * Collection of urine * Collection of stool samples * Collection of clinical, paraclinical data, and exposure questionnaire


Locations(1)

CHU de Poitiers

Poitiers, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06809660


Related Trials